Physician Clinical Trial Policy (CTP) Neurological Ischemia Lower Extremity Pain and Swelling

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Lower Extremity Swelling Acute
Interventions
DEVICE

Anodyne

Subjects will be treated with MIRE therapy using the Anodyne® device within 72 hours of previous treatments, and in accordance with the Anodyne® package insert indications for use 30 to 45 minutes professional units on power setting of 8,. In addition, patients will undergo TENS therapy with the use of either the Avazzia® Pro Sport or TENS 3000 (for no less than 30 mins, both on label) in accordance with the indications for use of each TENS device, for a minimum of 15 minutes at the subjective site for pain and each vertebrae nerve base, when impairment is confirmed with the objective Small Pain Fiber (SPF) Nerve Conduction Study (NCS) test performed.

All Listed Sponsors
lead

American Association of Sensory Electrodiagnostic Medicine

INDUSTRY

NCT01979367 - Physician Clinical Trial Policy (CTP) Neurological Ischemia Lower Extremity Pain and Swelling | Biotech Hunter | Biotech Hunter